Feliciano Patricia R, Carroll Kate S, Drennan Catherine L
Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, United States.
ACS Omega. 2021 May 17;6(21):13756-13765. doi: 10.1021/acsomega.1c01043. eCollection 2021 Jun 1.
Tuberculosis (TB) is the deadliest infectious disease in the world. In , the first committed step in sulfate assimilation is the reductive cleavage of adenosine-5'-phosphosulfate (APS) to form adenosine-5'-phosphate (AMP) and sulfite by the enzyme APS reductase (APSR). The vital role of APSR in the production of essential reduced-sulfur-containing metabolites and the absence of a homologue enzyme in humans makes APSR a potential target for therapeutic interventions. Here, we present the crystal structure of the [4Fe-4S] cluster-containing APSR from (MtbAPSR) and compare it to previously determined structures of sulfonucleotide reductases. We further present MtbAPSR structures with substrate APS and product AMP bound in the active site. Our structures at a 3.1 Å resolution show high structural similarity to other sulfonucleotide reductases and reveal that APS and AMP have similar binding modes. These studies provide structural data for structure-based drug design aimed to combat TB.
结核病(TB)是世界上最致命的传染病。在[具体生物名称未给出]中,硫酸盐同化的第一步关键反应是由腺苷-5'-磷酸硫酸还原酶(APSR)将腺苷-5'-磷酸硫酸(APS)还原裂解为腺苷-5'-磷酸(AMP)和亚硫酸盐。APSR在产生含必需还原态硫的代谢产物过程中发挥着至关重要的作用,且人类体内不存在同源酶,这使得APSR成为治疗干预的潜在靶点。在此,我们展示了来自[具体生物名称未给出](MtbAPSR)的含[4Fe-4S]簇的APSR的晶体结构,并将其与先前确定的硫核苷酸还原酶结构进行比较。我们还展示了活性位点结合有底物APS和产物AMP的MtbAPSR结构。我们分辨率为3.1 Å的结构显示出与其他硫核苷酸还原酶高度的结构相似性,并揭示APS和AMP具有相似的结合模式。这些研究为旨在对抗结核病的基于结构的药物设计提供了结构数据。